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How does metformin affect the physiology, behavior, 
and metabolism of Drosophila melanogaster?
Specifically, how does the drug affect food 
consumption, body weight, sleep, and starvation 
resistance?
All experiments involved treatment with fly food 
supplemented with metformin in concentrations of 0-
10.0 mM
• Food consumption: ConEx method8 on 
supplemented food for 10 days
• Body weight: Empty tubes were pre-weighed, 
then flies were added and weighed before and 
after above treatment.
• Sleep: Drosophila Activity Monitoring (DAM) 
system following treatment.
• Starvation resistance: Metformin treatment 
followed by transfer to a vial with a wet tissue. 
Live flies were counted every 6-10 hours.
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• Metformin is a first-line drug used in the treatment 
of type II diabetes mellitus. 
• It lowers blood glucose levels and increases 
insulin sensitivity1. 
• Despite its widespread use2, the degree to which it 
affects aspects of behavior and metabolism 
unrelated to diabetes is not fully understood.
• Beneficial effects in numerous model organisms, 
including decreased triglyceride levels, lifespan 
extension, and slowed tumor growth3-6, suggest 
that metformin could treat a range of non-diabetic 
conditions in humans, provided more research is 
done on the lesser-known effects of the drug.
• The molecular pathway by which metformin 
functions is conserved between humans and 
Drosophila melanogaster. We used the latter 
organism to conduct a preliminary assessment of 
metformin’s impact on metabolism and physiology.
Figure 1: Metformin Increases Food Consumption
Figure 3: Metformin Does Not Significantly Affect Sleep
Figure 4: Metformin Does Not Significantly Affect 
Starvation Stress
Figure 2: Metformin Affects Body Weight
• Flies were weighed after 
treatment with metformin
• Statistically significant increase 
in body weight at 10 mM, 
significant decrease at 0.5 mM 
(t-test, p<0.05)
• Treatment at 4 concentrations 
showed a trend towards longer 
survival times in flies removed 
from a food source
• 5 mM survival compared to 
control was nearly significant (t-
statistic of 0.064, p<0.05)
• At 10 mM, metformin slightly 
decreased mean survival time 
compared to the control
• Metformin did not significantly affect sleep at most concentrations
• An exception: At 1 mM, an increase in sleep was noted
• Metformin significantly increases food 
consumption in a dosage-dependent manner. 
• The data also suggests a trend towards 
increased body weight with higher dosages, 
though the effect is not consistent enough to 
draw strong conclusions at this time. One 
reason for the decrease in weight at low 
concentrations could be that metformin’s 
triglyceride-lowering effect9 is overshadowed by 
increased feeding at high concentrations.
• At lower concentrations (1 mM), metformin 
increased sleep. This could suggest a link 
between metabolism and sleep.
• Treated flies were less vulnerable to starvation 
stress up to a drug concentration of 5 mM. The 
lower mean survival time at 10 mM suggests 
that metformin increases sensitivity to starvation 
stress at higher concentrations.
• Further work should include a genome-wide 
association study on these changes in 
Drosophila Melanogaster. This will reveal the 
genes that play a role in increased food 
consumption, which was the strongest trend 
observed in this preliminary study.
• Results from ConEx analysis 
of dye excreted on vial walls
• Clear trend of increased food 
consumption in a dosage-
dependent manner
• Significant increase 
compared to control in 5 mM 
and 10 mM flies (t-test, 
p<0.05)
